Species: Moryella sp. HMT-097 (HMT-0097) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0097: [Body Sites Data]
[Taxon Description]
| Life Page: Moryella sp. HMT-097
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.01 | 0.01 | 0.01 | 0.02 | 0.07 | 0.07 | 0.17 | 0.46 | 0.45 | 0.43 | 0.02 | 0 | 0 | 0.03 | 0 | 0 | 0.01 | 0.02 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.04 | 0.14 | 0.05 | 0.05 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 |
| 90thp | 0.01 | 0.02 | 0.03 | 0.03 | 0.15 | 0.07 | 0.33 | 0.97 | 1.26 | 0.98 | 0.01 | 0 | 0 | 0.03 | 0 | 0.01 | 0.01 | 0.03 |
| Stdev | 0.01 | 0.03 | 0.03 | 0.04 | 0.12 | 0 | 0.21 | 0.39 | 0.51 | 0.46 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.06 |
| Prev(%) | 4.17 | 7.09 | 4.17 | 13.33 | 15.48 | 100.00 | 25.00 | 85.71 | 54.55 | 89.83 | 3.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0.53 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0 | 0.01 | 0.01 | 0.07 | 0.19 | 0.16 | 0.31 | 0.35 | 0.38 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0.02 | 0.02 | 0.20 | 0.50 | 0.39 | 0.84 | 0.84 | 0.89 | 0 |
| Stdev | 0.01 | 0.02 | 0.02 | 0.12 | 0.30 | 0.25 | 0.42 | 0.39 | 0.46 | 0.01 |
| Prev(%) | 6.49 | 11.69 | 12.99 | 61.04 | 79.22 | 70.13 | 76.62 | 84.42 | 80.52 | 3.90 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to S. longum, S. sp. HMT 097, and S. sp. HMT 910 were assigned one-third to each taxon.
Reads equally close to S. longum, S. sp. HMT 097, and S. sp. HMT 910 were assigned one-third to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0 | 0.01 | 0.01 | 0.09 | 0.19 | 0.18 | 0.26 | 0.30 | 0.31 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0.02 | 0.01 | 0.25 | 0.48 | 0.51 | 0.66 | 0.91 | 0.80 | 0 |
| Stdev | 0.01 | 0.02 | 0.04 | 0.18 | 0.28 | 0.23 | 0.38 | 0.42 | 0.40 | 0 |
| Prev(%) | 10.13 | 17.57 | 16.22 | 61.49 | 79.73 | 81.08 | 81.08 | 79.05 | 83.78 | 0.70 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0.26 | 0.75 | 0.43 | 0.77 | 0.86 | 0.94 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0.64 | 1.81 | 1.10 | 2.04 | 2.03 | 2.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0.44 | 1.06 | 0.58 | 1.02 | 1.04 | 1.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 66.00 | 80.82 | 80.66 | 81.00 | 89.05 | 87.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.02 | 0.06 | 0.39 | 0.07 | 0.09 | 0.36 | 0.35 | 0.38 | 0.70 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| 90thp | 0.07 | 0.08 | 0.97 | 0.21 | 0.22 | 0.81 | 0.60 | 0.68 | 1.95 | 0 |
| Stdev | 0.05 | 0.19 | 1.03 | 0.10 | 0.16 | 0.58 | 0.66 | 0.77 | 1.51 | 0 |
| Prev(%) | 54.05 | 73.53 | 67.44 | 80.00 | 78.57 | 86.00 | 93.94 | 87.10 | 92.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes

